Surmodics logo

Surmodics share price today

(SRDX)

Surmodics share price is $39.75 & ₹3,377.80 as on 21 Dec 2024, 2.30 'hrs' IST

$39.75

-0.16

(-0.4%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Surmodics share price in Dollar and Rupees. Guide to invest in Surmodics from India. Also see the sentimental analysis on Indian investors investing in Surmodics. Get details on the Indian mutual funds that are investing in Surmodics. Get Analyst recommendations and forecasts along with all the Surmodics's financials.

Surmodics share price movements

  • Today's Low: $39.60
    Today's High: $40.18

    Day's Volatility :1.43%

  • 52 Weeks Low: $25.17
    52 Weeks High: $42.44

    52 Weeks Volatility :40.69%

Surmodics Returns

PeriodSurmodics IncSector (Health Care)Index (Russel 2000)
3 Months
1.04%
-11.1%
0.0%
6 Months
-5.27%
-6.0%
0.0%
1 Year
7.58%
2.7%
0.0%
3 Years
-17.0%
0.6%
-19.7%

Surmodics Key Statistics

in dollars & INR

Previous Close
$39.91
Open
$40.1
Today's High
$40.175
Today's Low
$39.6
Market Capitalization
$571.8M
Today's Volume
$158.0K
52 Week High
$42.44
52 Week Low
$25.17
Revenue TTM
$126.1M
EBITDA
$6.8M
Earnings Per Share (EPS)
$-0.82
Profit Margin
-9.16%
Quarterly Earnings Growth YOY
4.36%
Return On Equity TTM
-9.67%

How to invest in Surmodics from India?

It is very easy for Indian residents to invest directly in Surmodics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Surmodics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Surmodics or SRDX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Surmodics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Surmodics shares which would translate to 0.021 fractional shares of Surmodics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Surmodics, in just a few clicks!

Returns in Surmodics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Surmodics investment value today

Current value as on today

₹1,09,774

Returns

₹9,774

(+9.77%)

Returns from Surmodics Stock

₹7,578 (+7.58%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Surmodics

67%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Surmodics on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 67% more investors are searching Surmodics in the last 30 days versus the previous period.

Global Institutional Holdings in Surmodics

  • BlackRock Inc

    8.17%

  • AllianceBernstein L.P.

    7.26%

  • Beryl Capital Management LLC

    6.90%

  • Vanguard Group Inc

    5.61%

  • Morgan Stanley - Brokerage Accounts

    5.25%

  • Soleus Capital Management, L.P.

    4.45%

Analyst Recommendation on Surmodics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Surmodics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Surmodics

What analysts predicted

Upside of 8.18%

Current:

$39.75

Target:

$43.00

Insights on Surmodics

  • Price Movement

    In the last 7 days, SRDX stock has moved down by -0.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 30.34M → 33.22M (in $), with an average increase of 8.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -7.55M → -3.44M (in $), with an average increase of 119.0% per quarter
  • SRDX vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 50.4%
  • SRDX vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 116.4% return, outperforming this stock by 131.4%
  • Price to Sales

    ForSRDX every $1 of sales, investors are willing to pay $4.5, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Surmodics Financials in INR & Dollars

FY19Y/Y Change
Revenue
$100.1M
↑ 23.04%
Net Income
$7.6M
↓ 270.34%
Net Profit Margin
7.59%
↑ 13.07%
FY20Y/Y Change
Revenue
$94.9M
↓ 5.21%
Net Income
$1.1M
↓ 85.21%
Net Profit Margin
1.18%
↓ 6.41%
FY21Y/Y Change
Revenue
$105.1M
↑ 10.83%
Net Income
$4.2M
↑ 277.29%
Net Profit Margin
4.03%
↑ 2.85%
FY22Y/Y Change
Revenue
$100.0M
↓ 4.93%
Net Income
$-27.3M
↓ 743.71%
Net Profit Margin
-27.29%
↓ 31.32%
FY23Y/Y Change
Revenue
$132.6M
↑ 32.65%
Net Income
$-1.5M
↓ 94.37%
Net Profit Margin
-1.16%
↑ 26.13%
FY24Y/Y Change
Revenue
$126.1M
↓ 4.91%
Net Income
$-11.5M
↑ 651.43%
Net Profit Margin
-9.15%
↓ 7.99%
Q2 FY23Q/Q Change
Revenue
$52.5M
↑ 92.97%
Net Income
$7.3M
↓ 195.0%
Net Profit Margin
14.0%
↑ 42.43%
Q3 FY23Q/Q Change
Revenue
$28.0M
↓ 46.71%
Net Income
$6.7M
↓ 8.88%
Net Profit Margin
23.93%
↑ 9.93%
Q4 FY23Q/Q Change
Revenue
$30.6M
↑ 9.23%
Net Income
$-786.0K
↓ 111.74%
Net Profit Margin
-2.57%
↓ 26.5%
Q1 FY24Q/Q Change
Revenue
$32.0M
↑ 4.6%
Net Income
$247.0K
↓ 131.42%
Net Profit Margin
0.77%
↑ 3.34%
Q2 FY24Q/Q Change
Revenue
$30.3M
↓ 5.06%
Net Income
$-7.6M
↓ 3158.3%
Net Profit Margin
-24.9%
↓ 25.67%
Q3 FY24Q/Q Change
Revenue
$33.2M
↑ 9.51%
Net Income
$-3.4M
↓ 54.34%
Net Profit Margin
-10.38%
↑ 14.52%
FY19Y/Y Change
Profit
$33.6M
↑ 27.26%
FY20Y/Y Change
Profit
$29.4M
↓ 12.5%
FY21Y/Y Change
Profit
$41.2M
↑ 40.42%
FY22Y/Y Change
Profit
$29.0M
↓ 29.65%
FY23Y/Y Change
Profit
$61.0M
↑ 110.43%
FY24Y/Y Change
Profit
$93.1M
↑ 52.48%
Q2 FY23Q/Q Change
Profit
$34.3M
↑ 302.18%
Q3 FY23Q/Q Change
Profit
$11.2M
↓ 67.27%
Q4 FY23Q/Q Change
Profit
$13.1M
↑ 16.47%
Q1 FY24Q/Q Change
Profit
$24.0M
↑ 83.27%
Q2 FY24Q/Q Change
Profit
$21.0M
↓ 12.33%
Q3 FY24Q/Q Change
Profit
$24.6M
↑ 16.79%
FY19Y/Y Change
Operating Cash Flow
$8.0M
↓ 76.39%
Investing Cash Flow
$9.8M
↓ 141.51%
Financing Cash Flow
$-11.0M
↑ 225.05%
FY20Y/Y Change
Operating Cash Flow
$14.0M
↑ 74.3%
Investing Cash Flow
$-9.1M
↓ 192.95%
Financing Cash Flow
$-4.6M
↓ 57.86%
FY21Y/Y Change
Operating Cash Flow
$15.4M
↑ 9.84%
Investing Cash Flow
$-25.2M
↑ 178.38%
Financing Cash Flow
$10.2M
↓ 320.03%
FY22Y/Y Change
Operating Cash Flow
$-17.2M
↓ 211.92%
Investing Cash Flow
$6.2M
↓ 124.68%
Financing Cash Flow
$-375.0K
↓ 103.67%
Q2 FY23Q/Q Change
Operating Cash Flow
$25.9M
↓ 544.48%
Investing Cash Flow
$-470.0K
↓ 34.99%
Financing Cash Flow
$-19.0K
↓ 97.61%

Surmodics Technicals Summary

Sell

Neutral

Buy

Surmodics is currently in a neutral trading position according to technical analysis indicators.

Surmodics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Surmodics Inc
1.43%
-5.27%
7.58%
-17.0%
-6.32%
Stryker Corporation
-6.55%
7.53%
22.55%
38.08%
71.54%
Boston Scientific Corp.
-2.79%
15.96%
59.12%
110.98%
96.7%
Edwards Lifesciences Corp.
6.29%
-17.03%
-1.35%
-41.48%
-5.43%
Abbott Laboratories
-2.58%
8.48%
4.77%
-17.81%
30.77%
Medtronic Plc
-4.38%
-0.01%
-1.09%
-20.04%
-28.85%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Surmodics Inc
43.13
NA
3.9
-0.56
-0.1
-0.01
NA
8.38
Stryker Corporation
38.32
38.32
2.51
12.06
0.19
0.07
0.01
52.86
Boston Scientific Corp.
73.27
73.27
1.61
2.46
0.09
0.05
NA
14.05
Edwards Lifesciences Corp.
28.88
28.88
6.79
2.55
0.19
0.11
NA
16.18
Abbott Laboratories
34.17
34.17
2.17
4.68
0.15
0.06
0.02
22.94
Medtronic Plc
24.46
24.46
1.46
5.2
0.08
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Surmodics Inc
Buy
$571.8M
-6.32%
43.13
-9.16%
Stryker Corporation
Buy
$136.1B
71.54%
38.32
16.34%
Boston Scientific Corp.
Buy
$130.7B
96.7%
73.27
11.26%
Edwards Lifesciences Corp.
Buy
$44.1B
-5.43%
28.88
65.86%
Abbott Laboratories
Buy
$195.0B
30.77%
34.17
13.99%
Medtronic Plc
Buy
$102.6B
-28.85%
24.46
12.06%

About Surmodics

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Organization
Surmodics
Employees
0
CEO
Mr. Gary R. Maharaj
Industry
Health Technology

Management People of Surmodics

NameTitle
Mr. Gary R. Maharaj
CEO, President & Director
Mr. Timothy J. Arens
Senior VP of Finance & Information Technology and CFO
Mr. Charles W. Olson
Senior VP & President of Medical Device Coatings
Mr. John D. Manders
Corporate Controller, VP of Finance & Principal Accounting Officer
Joel Suiter
Director of Corporate Development
Mr. Joseph J. Stich
Senior VP of Human Resources & President of In Vitro Diagnostics

Important FAQs about investing in Surmodics from India :

What is Surmodics share price today?

Surmodics share price today stands at $39.75, Open: $40.10 ; Previous Close: $39.91 ; High: $40.18 ; Low: $39.60 ; 52 Week High: $42.44 ; 52 Week Low: $25.17. The stock opens at $40.10, after a previous close of $39.91. The stock reached a daily high of $40.18 and a low of $39.60, with a 52-week high of $42.44 and a 52-week low of $25.17.

Can Indians buy Surmodics shares?

Yes, Indians can invest in the Surmodics (SRDX) from India.

With INDmoney, you can buy Surmodics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Surmodics at zero transaction cost.

How can I buy Surmodics shares from India?

It is very easy to buy Surmodics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Surmodics be purchased?

Yes, you can buy fractional shares of Surmodics with INDmoney app.

What are the documents required to start investing in Surmodics stocks?

To start investing in Surmodics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Surmodics

Today’s highest price of Surmodics (SRDX) is $40.18.

Today’s lowest price of Surmodics (SRDX) is $39.60.

What is today's market capitalisation of Surmodics

Today's market capitalisation of Surmodics SRDX is 571.8M

What is the 52 Week High and Low Range of Surmodics

  • 52 Week High

    $42.44

  • 52 Week Low

    $25.17

What are the historical returns of Surmodics?

  • 1 Month Returns

    1.43%

  • 3 Months Returns

    -5.27%

  • 1 Year Returns

    7.58%

  • 5 Years Returns

    -6.32%

Who is the Chief Executive Officer (CEO) of Surmodics

Mr. Gary R. Maharaj is the current Chief Executive Officer (CEO) of Surmodics.